Qisda Corporation

TWSE:2352 Rapport sur les actions

Capitalisation boursière : NT$44.7b

Qisda Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Peter Chen

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur général12.7yrs
Propriété du PDG0.1%
Durée moyenne d'occupation des postes de direction3.7yrs
Durée moyenne du mandat des membres du conseil d'administration4.8yrs

Mises à jour récentes de la gestion

Recent updates

Mise à jour du récit • Jun 26

2352: Higher Discount Rate And Compressed P/E Will Shape A Fair Outlook

Analysts have revised their price target for Qisda to NT$33.20 from NT$41.46, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for Qisda No recent Qisda specific news items were identified in the provided sources.
Mise à jour du récit • Jun 11

2352: Refined Assumptions And Lower Multiple Will Shape Future Upside Potential

Analysts have trimmed their price target on Qisda to NT$32.60 from about NT$36.73, reflecting updated assumptions that combine a slightly higher discount rate and revised expectations for revenue growth, profit margin, and future P/E. What's in the News No recent news items or key developments were provided for Qisda, so there are currently no specific events to highlight from the supplied sources.
Mise à jour du récit • Apr 02

2352: Steady Fair Value And Refined Assumptions Will Support Future Upside

Analysts have kept Qisda's fair value view broadly unchanged, with only very small tweaks to inputs like the discount rate and future P/E. These adjustments feed into a steady NT$36.73 price target that signals continued confidence in their existing valuation framework.
Mise à jour du récit • Mar 19

2352: Higher Profitability Assumptions And Steady Fair Value Will Support Future Upside

Analysts kept their NT$36.73 price target for Qisda unchanged, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E that effectively offset one another in their updated model. Valuation Changes Fair Value: NT$36.73 is unchanged in the updated model, indicating no revision to the overall equity value per share.
Mise à jour du récit • Mar 04

2352: Stable Assumptions And Slightly Higher P E Will Support A Higher Share Price

Analysts have made a small upward adjustment to their Qisda price target to reflect updated assumptions around the discount rate and future P/E. They have kept their fair value estimate broadly unchanged at about NT$36.73 per share.
Mise à jour du récit • Feb 18

2352: Stable Assumptions And Lower Discount Rate Will Support A Higher Share Price

Analysts have modestly adjusted their price target on Qisda to NT$36.73, reflecting fine tuning of assumptions such as a slightly lower discount rate, stable revenue growth and profit margin expectations, and a marginally revised future P/E multiple. Valuation Changes Fair Value: NT$36.73 is unchanged, indicating the updated inputs leave the core valuation estimate essentially the same.
Nouveau récit • Feb 06

AI Hardware Delays And Medical Regulatory Risks Will Eventually Support A Gradual Turnaround

Catalysts About Qisda Qisda is a diversified electronics and solutions group with businesses spanning information technology hardware, medical equipment and services, smart business solutions and networking and communications. What are the underlying business or industry changes driving this perspective?
Mise à jour du récit • Feb 03

2352: Steady Assumptions And Higher Required Return Will Support A Higher Share Price

Analysts have kept their price target for Qisda steady at US$36.73. Modest tweaks to inputs such as the discount rate and assumed future P/E suggest only fine tuning rather than a shift in their underlying outlook.
Mise à jour du récit • Jan 19

2352: Stable Long Term Assumptions Will Support A Higher Future Share Price

Analysts have kept their Qisda fair value estimate steady at about $36.73 per share, with only very small model updates to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. Valuation Changes Fair Value: The intrinsic value estimate is unchanged at about NT$36.73 per share.
Mise à jour du récit • Jan 05

2352: Stable Assumptions And Earnings Outlook Will Support Stronger Share Price

Analysts have kept their price target for Qisda broadly in line with prior estimates. The changes reflect only very small model tweaks around discount rate, revenue growth, profit margin and future P/E assumptions, rather than any major change in their view of the stock.
Mise à jour du récit • Dec 14

2352: Stable Earnings Outlook Should Support Stronger Future Share Price Performance

Analysts have raised their price target on Qisda modestly to reflect slightly lower discount rates and a marginally improved long term earnings outlook, while keeping fair value estimates effectively unchanged at around $36.73 per share. Valuation Changes Fair Value Estimate: Unchanged at approximately NT$36.73 per share, indicating no material revision in the intrinsic value assessment.
Mise à jour du récit • Nov 29

2352: Lower Profit Margins Will Give Way To Future Share Price Upside

Analysts have slightly revised their price target for Qisda downward from $37.80 to $36.73. This change is attributed to moderate adjustments to profit margin expectations and future earnings estimates.
Mise à jour du récit • Nov 15

2352: Earnings Strength and Higher Margins Will Support Upcoming Share Upside

Narrative Update: Qisda Analyst Price Target Revised Analysts have raised their price target for Qisda, increasing it from $37.80 to $37.80. This revision is based on slightly higher expected revenue growth and profit margins, along with a modest uptick in the discount rate and projected future price-to-earnings ratio.
Mise à jour du récit • Nov 01

2352: Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda Analyst Price Target Updated Analysts have made a minor adjustment to Qisda’s price target, keeping it steady at $37.80. Recent analysis indicates only incremental changes to underlying valuation metrics.
Mise à jour du récit • Oct 17

Investments In AIoT And Medical Services Will Boost Future Profitability

Analysts have maintained their price target for Qisda at $37.80, citing stable financial indicators and minimal changes to key valuation metrics as supporting rationale for holding their previous outlook. Valuation Changes Fair Value: Remained unchanged at NT$37.80.
Mise à jour du récit • Oct 03

Investments In AIoT And Medical Services Will Boost Future Profitability

Analysts have raised their price target for Qisda from $31 to approximately $37.80, citing an adjusted fair value estimate. Other core financial projections remain consistent.
Mise à jour du récit • Sep 17

Investments In AIoT And Medical Services Will Boost Future Profitability

The notable downward revision in Qisda’s consensus analyst price target is primarily driven by a significant decline in net profit margin and a slight decrease in future P/E, lowering fair value from NT$35.75 to NT$31.00. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly fallen from NT$35.75 to NT$31.00.
Mise à jour du récit • Sep 02

Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda’s higher consensus price target reflects a sharp increase in its expected future P/E ratio, signaling improved earnings growth prospects or investor confidence, raising fair value from NT$28.50 to NT$35.75. Valuation Changes Summary of Valuation Changes for Qisda The Consensus Analyst Price Target has significantly risen from NT$28.50 to NT$35.75.
User avatar
Nouveau récit • Feb 21

Investments In AIoT And Medical Services Will Boost Future Profitability

Qisda’s focus on AIoT and AI technologies may increase revenue streams and improve gross margins through innovation in smart automation solutions.
Article d’analyse • Mar 12

Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture

The market wasn't impressed with the soft earnings from Qisda Corporation ( TWSE:2352 ) recently. We did some further...
Article d’analyse • Mar 09

Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Qisda Corporation ( TWSE:2352 ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...
Article d’analyse • Feb 29

Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

PDG

Peter Chen (65 yo)

12.7yrs
Titularisation

Mr. Chi-Hong Chen, also known as Peter, is Non Executive Chairperson of BenQ BM Holding Cayman Corporation from March 22, 2024 and serves as its Director since May 27, 2013 and serves as President of BenQ...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Chi-Hong Chen
CEO & Chairmanno datapas de données0.13%
NT$ 56.0m
Shu-Fen Ko
Representative Director & Presidentno datapas de donnéespas de données
Chiu-Chin Hung
VP, CFO & Accounting Officerno datapas de données0.038%
NT$ 16.8m
Danny Lin
VP and Chief HR4.7yrspas de données0.015%
NT$ 6.6m
Wen-Fang Huang
President of the Network Communication Business Unit2.7yrspas de donnéespas de données
Harry Yang
VP & President of the Medical Devices Products Groupno datapas de donnéespas de données
Eric Lee
GM of Manufacturing Operations & MD of Qisda China2.7yrspas de donnéespas de données
L.. S. Wang
CIOno datapas de donnéespas de données
Li-Wen Huang
Chief Information Security Officer6.5yrspas de donnéespas de données
Daniel Hsueh
VP & GM of Information Technology Business Groupno datapas de donnéespas de données
Yu-Chin Lin
VP & GM of Commercial & Industrial Business Groupno datapas de données0.0031%
NT$ 1.4m
Wen-Hsing Tzeng
General Manager of Business Solutions Business Groupno datapas de donnéespas de données
3.7yrs
Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de 2352 est considérée comme expérimentée (ancienneté moyenne 3.7 ans).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Chi-Hong Chen
CEO & Chairman12.7yrspas de données0.13%
NT$ 56.0m
Shu-Fen Ko
Representative Director & Presidentno datapas de donnéespas de données
Han-Chou Huang
Vice Chairman & Group Chief Strategy Officer9.3yrspas de données0.045%
NT$ 20.0m
Chien-Pin Chen
Director3.3yrspas de données0.000030%
NT$ 13.4k
Lo-Yu Yen
Independent Director6.3yrspas de donnéespas de données
Jyuo-Min Shyu
Independent Director6.3yrspas de donnéespas de données
Liang-Gee Chen
Independent Director3.3yrspas de donnéespas de données
Chiu-Lien Lin
Independent Director3.3yrspas de donnéespas de données
Shu-Chun Huang
Independent Director3.3yrspas de donnéespas de données
4.8yrs
Durée moyenne de l'emploi
65yo
Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 2352 sont considérés comme expérimentés (ancienneté moyenne 4.8 ans).

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/09/15 05:09
Cours de l'action en fin de journée2026/09/15 00:00
Les revenus2026/06/30
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Qisda Corporation est couverte par 7 analystes. 2 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Changrong ChenCapital Securities Corporation
Nicholas TeoCLSA
Joey ChengGoldman Sachs